These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5331065)

  • 81. [Clinical evaluation of Envacar in the treatment of hypertension].
    Kocemba J; Mareczek S
    Przegl Lek; 1968; 24(2):330-2. PubMed ID: 4867414
    [No Abstract]   [Full Text] [Related]  

  • 82. [Guancydine. Clinical evaluation of a new hypotensive agent].
    da Silva JA; Antunes NM; Laraia Cde B; Fraga Filho C
    Rev Bras Med; 1972 Jan; 29(1):42-7. PubMed ID: 5017517
    [No Abstract]   [Full Text] [Related]  

  • 83. Treatment of hypertension with Guanoxan.
    Oza GG
    J Assoc Physicians India; 1966 Mar; 14(3):175-80. PubMed ID: 5324599
    [No Abstract]   [Full Text] [Related]  

  • 84. [Initial results in the use of Ro 5-3307 in the treatment of arterial hypertension].
    Faerchtein I; Kastansky I; Pereira CJ; Kac LB; de Brito WF; Roque AF
    Hospital (Rio J); 1965 Sep; 68(3):629-34. PubMed ID: 5322815
    [No Abstract]   [Full Text] [Related]  

  • 85. A clinical trial of polythiazide and guanoxan in the treatment of hypertension.
    Mann RD; Jackson D
    Practitioner; 1966 Feb; 196(172):293-9. PubMed ID: 5322962
    [No Abstract]   [Full Text] [Related]  

  • 86. Recommendations from the Consensus Conference on Hypertension in the Elderly.
    Larochelle P; Bass MJ; Birkett NJ; De Champlain J; Myers MG
    CMAJ; 1986 Oct; 135(7):741-5. PubMed ID: 3756700
    [No Abstract]   [Full Text] [Related]  

  • 87. [Blood pressure and the aged. Hazards of hypotensive therapy].
    Jeanjean P
    Soins; 1979 Jul 5-20; 24(13-14):17-8. PubMed ID: 256664
    [No Abstract]   [Full Text] [Related]  

  • 88. [The ideal antihypertensive drug].
    Peris Arso A
    Med Clin (Barc); 1987 May; 88(20):804-6. PubMed ID: 3298879
    [No Abstract]   [Full Text] [Related]  

  • 89. Ethacrynic acid. A non-diabetogenic diuretic.
    Hutchison JC
    Pa Med; 1969 Aug; 72(8):65-7. PubMed ID: 4894968
    [No Abstract]   [Full Text] [Related]  

  • 90. [Clinical trial of a new sympathoplegic hypotensive agent].
    Lebacq E; Tirzmalis A; Gossart J; Gilon L; Stenier P
    Sem Hop; 1969 Dec; 45(50):3197-202. PubMed ID: 4312510
    [No Abstract]   [Full Text] [Related]  

  • 91. Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure.
    Athanassiadis D; Cranston WI; Juel-Jensen BE; Oliver DO
    Br Med J; 1966 Sep; 2(5516):732-5. PubMed ID: 5917391
    [No Abstract]   [Full Text] [Related]  

  • 92. Antihypertensive therapy and cancer risks?
    Hedner T; Narkiewicz K; Kjeldsen S; Oparil S
    Blood Press; 2011 Jun; 20(3):127-8. PubMed ID: 21599451
    [No Abstract]   [Full Text] [Related]  

  • 93. A comparative clinical trial of guanoxan and guanethidine in essential hypertension.
    Ruedy J; Davies RO
    Clin Pharmacol Ther; 1967; 8(1):38-47. PubMed ID: 5334083
    [No Abstract]   [Full Text] [Related]  

  • 94. [Clinical study of a new product with hypotensive action: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Novelli E; Grillo A
    Minerva Cardioangiol; 1973 Nov; 21(11):748-53. PubMed ID: 4776571
    [No Abstract]   [Full Text] [Related]  

  • 95. [Clinical administration of hydralazin (Depressan) in essential and renal hypertension].
    Teichmann G; Harms R; Wedler B; Rohmann H
    Z Arztl Fortbild (Jena); 1972 Nov; 66(21):1112-6. PubMed ID: 4576549
    [No Abstract]   [Full Text] [Related]  

  • 96. [Hypotensive action of prostaglandin E1].
    Otsuka Y; Saito T; Kiyono M; Ono I; Abe K
    Nihon Rinsho; 1974 Aug; 32(8):2737-40. PubMed ID: 4474478
    [No Abstract]   [Full Text] [Related]  

  • 97. Nitroprusside revisited.
    Mani MK
    Br Med J; 1971 Aug; 3(5771):407-8. PubMed ID: 5566620
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical trial of a new hypotensive agent.
    Verstraete M; Hendrickx H; Amery A
    Med Pharmacol Exp Int J Exp Med; 1966; 14(5):443-56. PubMed ID: 5335039
    [No Abstract]   [Full Text] [Related]  

  • 99. [Marginal notes on ketanserin].
    van der Pol JM; Oei TT
    Ned Tijdschr Geneeskd; 1989 Jan; 133(2):82-3. PubMed ID: 2915731
    [No Abstract]   [Full Text] [Related]  

  • 100. Comparing the SPRINT and the HOPE-3 Blood Pressure Trial.
    Whelton PK; Reboussin DM; Fine LJ
    JAMA Cardiol; 2016 Nov; 1(8):855-856. PubMed ID: 27604076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.